Komori
Rion (6823) · InitiativeAdvanced

Developing markets with cutting-edge models, pharmaceutical applications and biological particle counters

First written in FY2019. 3 of 5 entries say "Advanced", first in FY2023. Latest entry: FY2026.

5entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019RestatedFY2024-Q1AdvancedFY2025 – FY20262019: 120192020: 020202021: 020212022: 020222023: 220232024: 020242025: 120252026: 12026
Same theme, other companies
Expansion of inspection technology into new applications and marketsA theme 6 companies write about · 0 as a headwind · 7 as a tailwind

The whole theme swung hardest in 2026: 1 of 6 companies on the "Worse" side.

4 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「In the fine-particle measurement instruments business, in addition to continuing to respond to demand for leading-edge models driven by semiconductor miniaturization, new semiconductor manufacturing plants and capacity expansions are expected as the semiconductor market, particularly generative AI-related applications, continues to grow. We will secure new projects and use our expanded production capacity to convert them into sales, thereby maintaining strong sales.」

    The company explicitly identified responding to leading-edge models, securing new generative AI-related semiconductor projects, and utilizing its expanded production capacity as market development initiatives.
  2. FY2025AdvancedAnnual report

    「In the fine-particle measurement instruments business, we will continue to generate strong sales by securing new generative AI-related projects in the semiconductor market and responding to demand for leading-edge models driven by semiconductor miniaturization.」

    For market development in the fine-particle measurement instruments business, the company explicitly identified securing new generative AI-related projects and responding to leading-edge models driven by semiconductor miniaturization as new initiatives.
  3. FY2024-Q1RestatedAnnual report

    「Amid continued active capital investment in the semiconductor-related market, sales of fine-particle counters used in semiconductor manufacturing plants have remained strong. Overseas demand for liquid-borne particle counters also remains robust, while domestic demand for airborne particle counters has increased.」

    The company continues to describe its market development through semiconductor miniaturization, overseas demand for liquid-borne particle counters, and domestic demand for airborne particle counters.
  4. FY2023Strengthening production capacity and specifying market development initiativesAnnual report

    「In addition to responding to demand for leading-edge models driven by miniaturization in the semiconductor-related market, we will improve production capacity by strengthening equipment and production technology, thereby addressing growing demand for our products.」

    The company explicitly identified responding to leading-edge models and improving production capacity by strengthening equipment and production technology as initiatives.
  5. FY2019First statedAnnual report

    「In the Fine Particle Measurement Instruments business, the company will address demand for cutting-edge models arising from miniaturization in the semiconductor-related market, expand sales in pharmaceutical-related markets, and develop new markets using biological particle counters.」

    For the first time, the company explicitly identified as initiatives responding to leading-edge models driven by semiconductor miniaturization, expanding sales in the pharmaceutical-related market, and developing new markets with biological particle counters.
Moved together

"Continuation of Research and Development Activities" moved the same way as this thread, in the same document, in 3 of its 5 moves.

333332★123456
  1. ★This thread
  2. 1Continuation of Research and Development Activities3×
  3. 2New hearing aid products launched3×
  4. 3Achieve ¥25 billion in revenue, a 15% operating margin and 10% ROE3×
  5. 4Securing domestic earnings and entering overseas markets for medical testing equipment3×
  6. 5Capturing demand in the environmental and industrial measurement markets and strengthening overseas sales3×
  7. 6Overall decline in revenue and profit2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Rion's next results are scheduled for 2026-10-29. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.